| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Common Stock | 270,978 | $2,306,022 | $8.51 | 02 Mar 2026 | Direct |
| LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Performance-Based Restricted Stock Units | 333,000 | $0 | $5.74 | 08 Jul 2025 | Direct |
| LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | Incentive Stock Option (Right to Buy) | 210,000 | 14 Apr 2025 | Direct | ||
| LIFECORE BIOMEDICAL, INC. \DE\ | Chief Legal & Administration | No Security beneficially owned | 0 | 14 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | 02 Mar 2026 | 1 | $0 | 4 | Chief Legal & Administration | 02 Mar 2026, 18:52 |
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | 08 Jul 2025 | 3 | -$90,270 | 4 | Chief Legal & Administration | 10 Jul 2025, 16:45 |
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | 14 Apr 2025 | 4 | $0 | 4 | Chief Legal & Administration | 16 Apr 2025, 16:38 |
| LFCR | LIFECORE BIOMEDICAL, INC. \DE\ | 14 Apr 2025 | 0 | $0 | 3 | Chief Legal & Administration | 16 Apr 2025, 16:37 |